Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTWO vs GSK✓SelectedUSD · GSKTTWO vs GSK performance historyLatest closeAs of+6.22%11/18
Stock and ETF performance explorer

TTWO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+354.7%
GSK return
+101.2%
Excess return
+253.5%
Maximum drawdown
-56.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+6.2%-1.3%+7.6%+6.5%
7D-6.4%-3.1%-3.2%-5.8%
30D+5.7%-0.9%+6.6%+5.8%
3M-10.6%-4.2%-6.5%-10.0%
6M-10.6%-1.6%-9.0%-10.5%
YTD-15.4%+2.6%-18.0%-16.8%
1Y-9.4%+6.2%-15.6%-11.6%
3Y+40.3%+55.0%-14.7%+22.1%
5Y+24.5%+42.8%-18.3%+8.9%
10Y+354.7%+102.1%+252.6%+238.3%
All+354.7%+101.2%+253.5%+238.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling